Colposcopy vs Hybrid Capture II Assay in detection of cervical human papilloma virus infection

European Journal of Gynaecological Oncology

Volumn 26, Issue 3, 2005, Pages 303-305

  Caruso, C ^a   Le Donne, M ^a,b   Antico, F ^a   De Meo, L ^a   La Spada, R ^a   Arrigo, A ^a   Triolo, O ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Atypical colposcopic findings; DNA Hybrid Capture II Assay; Human Papillomavirus

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; COLPOSCOPY; DEVICE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFECTION RISK; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PROBABILITY; SQUAMOUS CELL CARCINOMA; UTERINE CERVICITIS; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERUS BIOPSY; VIRUS DETECTION; VIRUS DIAGNOSIS; VIRUS INFECTION; VIRUS TYPING; WART VIRUS;

ADOLESCENT; ADULT; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TRIAGE; UTERINE CERVICAL DISEASES; UTERINE CERVICAL NEOPLASMS;

EID: 21044455870     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Walboomers J.M.M., Jacobs M.V., Manos M.M., Bosh F.X., Kummer J.A. et al., "Human papillomavirus is a necessary cause of invasive cervical cancer worldwide". J. Pathol., 1999, 189, 12.
2. Nobbenhuis M.A.E., Walboomers J.M.M., Heimerhorst T.J.M., Rozendaal L., Remmink A.J. et al.: "Relation of human papillomavirus status to cervical lesions and consequences for cervical cancer screening; a prospective study". Lancet, 1999, 354, 20.
3. Schiffman M.H., Bauer H.M., Hoover R.N. et al.: "Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia". J. Natl. Cancer Inst., 1993, 85, 958.
4. Solomon D.: "Chapter 14: role of triage testing in cervical cancer screening". J. Natl. Cancer Inst. Monogr., 2003, 31, 97.
5. Manos M.M., Kinney W.K., Hurley L.B., Sherman M.E., Shieh-Ngai S. et al.: "Identifying women with cervical neoplasia". JAMA, 1999, 281, 1605.
6. Cuzick J., Beverley E., Ho L., Terry G., Sapper H. et al.: "HPV testing in primary screening of older women". Br. J. Cancer, 1999, 81, 554.
7. Clavel C., Masure M., Bory J.P., Putaud I., Mangeonjean C. et al.: "Hybrid capture H-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women". Br. J. Cancer, 1999, 80, 1306.
8. Pretorius R.G., Peterson P., Novak S., Azizi F., Sadeghi M. et al.: "Comparison of two signal-amplification DNA tests for high-risk HPV as an aid to colposcopy". J. Reprod. Med., 2002, 47, 290.
9. Lonky N.M., Felix J.C., Naidu Y.M., Wolde-Tsadik G.: "Triage of atypical squamous cells of indetermined significance with hybrid capture II: colposcopy and hystologic Human Papilloma Virus correlation". Obstet. Gynecol., 2003, 101, 481.
10. Perovic M., Berisavac M., Kuljic-Kapulica N., Jovanovic T.: "Correlation between atypical colposcopy findings and detection of human papilloma virus (HPV) infection of the uterine cervix". Eur. J. Gynaecol. Oncol., 2002, 23, 42.
11. Castle P.E., Hillier S.L., Rabe L.K., Hildesheim A., Herrero R. et al.: "An association of cervical inflammation with high grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV)". Cancer Epidem. Biomark Prevent., 2001, 10, 1021.
12. Chan J.K., Monk B.J., Brewer C., Keefe K.A., Osann K., McMeekin S. et al.: "HPV infection and number of lifetime sexual partners are strong predictors of 'natural' regression of CIN 2 and 3". Br. J. Cancer, 2003, 89, 1062.
13. Cuzick J., Sasieni P., Davies P., Adams J, Normand C. et al.: "A systematic review of the role of human papillomavirus (HPV) testing within a cervical screening programme: summary and conclusions". Br. J. Cancer, 2000, 83, 561.
14. Nagai Y., Maehama T., Asato T., Kanazawa K. Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence?". Gynecol. Oncol., 2000, 79, 294.